Andrew Quillin, MD
Dermatology · Columbus, OHNPI 1205911898
Payments from drug & device makers
Across 327 payments — averaging $18.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$1K
- Sun Pharmaceutical Industries Inc.$474
- Novartis$240
- Regeneron Healthcare Solutions, Inc.$217
- Lilly USA, LLC$213
- plus $1K from 18 others
What the payments were for
- Food & beverage$5,16686%
- Education$81514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 181 | $2,597 |
| Johnson & Johnson | 39 | $1,080 |
| Sun Pharmaceutical Industries Inc. | 17 | $474 |
| Novartis | 13 | $240 |
| Regeneron Healthcare Solutions, Inc. | 9 | $217 |
| Lilly USA, LLC | 13 | $213 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 8 | $205 |
| UCB, Inc. | 7 | $121 |
| Krystal Biotech Inc | 1 | $106 |
| Sanofi | 5 | $100 |
| Journey Medical Corporation | 1 | $92 |
| Incyte Corporation | 6 | $85 |
| Pfizer | 4 | $74 |
| E.r. Squibb & Sons, L.L.C. | 3 | $53 |
| Galderma Laboratories, L.p. | 3 | $48 |
| LEO Pharma Inc. | 3 | $40 |
| Genentech USA, Inc. | 2 | $39 |
| Dermavant Sciences, Inc. | 2 | $38 |
| Arcutis Biotherapeutics, Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $35 |
| Merck | 2 | $27 |
| Dermira, Inc. | 2 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Aclaris Therapeutics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,981 in reported general payments places this provider in the 65th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 173 | $5,704 |
| Clobetasol Propionate | 118 | $5,345 |
| Minoxidil | 354 | $4,194 |
| Finasteride | 314 | $3,797 |
| Metronidazole | 86 | $3,548 |
| Ketoconazole | 130 | $3,456 |
| Fluorouracil | 51 | $3,259 |
| Spironolactone | 109 | $1,858 |
| ValacyclovirValacyclovir Hcl | 58 | $1,567 |
| ClaravisIsotretinoin | 19 | $1,467 |
| Doxycycline Hyclate | 73 | $1,383 |
| Triamcinolone Acetonide | 141 | $1,324 |
| Clindamycin Phosphate | 50 | $1,270 |
| Sulfacetamide Sodium | 15 | $1,199 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 50 | $1,196 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Columbus
- Jessica KaffenbergerColumbus$3.2M
- Benjamin BoguckiColumbus$2M
- Michelle ChambersColumbus$1.9M
- Kelly TylerColumbus$403K
- Nicholas BennerColumbus$356K
- Benjamin KaffenbergerColumbus$124K
- Stephanie FabbroColumbus$82K
- Shari Hicks-GrahamColumbus$68K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.